Skip to main content
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Labcorp Holdings Secures New $750 Million Term Loan

Tipranks - Sat Mar 21, 4:38PM CDT

Claim 70% Off TipRanks Premium

The latest update is out from Labcorp Holdings ( (LH) ).

On March 20, 2026, Labcorp Holdings Inc. and its subsidiary Laboratory Corporation of America Holdings entered into a new term loan credit agreement providing a $750 million senior unsecured term loan maturing on March 20, 2028. The facility, fully funded at closing, bears interest at a floating rate based on either SOFR plus a margin of 0.700% or a base rate with no additional margin.

The credit agreement includes customary representations, covenants and events of default, with limitations on additional debt at certain non‑guarantor subsidiaries, as well as restrictions on liens, mergers and major asset sales. It also requires Labcorp to maintain a maximum consolidated leverage ratio of 4.0x, with the ability to raise this temporarily to 4.5x for four quarters following material acquisitions under specified conditions, shaping the company’s financial flexibility and capital structure over the loan term.

The most recent analyst rating on (LH) stock is a Hold with a $300.00 price target. To see the full list of analyst forecasts on Labcorp Holdings stock, see the LH Stock Forecast page.

Spark’s Take on LH Stock

According to Spark, TipRanks’ AI Analyst, LH is a Outperform.

The score is driven by improving operational outlook and supportive technical momentum (price above key moving averages with positive MACD), partly offset by only solid—not exceptional—financial consistency (margin and FCF variability) and a relatively high P/E with a modest dividend yield.

To see Spark’s full report on LH stock, click here.

More about Labcorp Holdings

Labcorp Holdings Inc., through its subsidiary Laboratory Corporation of America Holdings, operates in the healthcare diagnostics industry, providing clinical laboratory testing and related services. The company focuses on delivering diagnostic solutions to healthcare providers, pharmaceutical companies and other stakeholders across the medical and life sciences markets.

Average Trading Volume: 684,716

Technical Sentiment Signal: Buy

Current Market Cap: $21.76B

Find detailed analytics on LH stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.